Literature DB >> 18704464

[Interdisciplinary point of contact between rheumatology and pneumology].

J Hermann1, G Kovacs, S Scheidl.   

Abstract

The lungs are involved in many inflammatory rheumatic diseases. We will focus on the most common clinical problems. In systemic sclerosis interstitial lung disease resulting in fibrosis and pulmonary arterial hypertension (PAH) resulting in right heart failure are the leading complications requiring close cooperation between specialists in rheumatology and pulmonology. In Sjogren's syndrome interstitial pneumonia, pleural and bronchial inflammation and rarely PAH will be the main pulmonary complications. Hypereosinophilic syndrome, eosinophilic pneumonia, and Churg-Strauss syndrome are conditions that show marked eosinophilia and can clinically be confused with asthma and allergic bronchopulmonary aspergillosis. These conditions mandate thorough investigation of the lungs including bronchoscopy and possibly open lung biopsy. Finally, patients for whom treatment with tumour necrosis factor blocking agents is planned should undergo interdisciplinary management to prevent tuberculosis activation or infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704464     DOI: 10.1007/s00393-008-0346-x

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  46 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  Clinical manifestations and early diagnosis of Sjögren syndrome.

Authors:  Stuart S Kassan; Haralampos M Moutsopoulos
Journal:  Arch Intern Med       Date:  2004-06-28

3.  HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome.

Authors:  P Langevitz; D Buskila; D D Gladman; G A Darlington; V T Farewell; P Lee
Journal:  Br J Rheumatol       Date:  1992-09

4.  Granulomatous infections due to tumor necrosis factor blockade: correction.

Authors:  Robert S Wallis; Michael Broder; John Wong; David Beenhouwer
Journal:  Clin Infect Dis       Date:  2004-10-15       Impact factor: 9.079

5.  Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

Authors:  Eric Hachulla; Virginie Gressin; Loïc Guillevin; Patrick Carpentier; Elisabeth Diot; Jean Sibilia; André Kahan; Jean Cabane; Camille Francès; David Launay; Luc Mouthon; Yannick Allanore; Kiet Phong Tiev; Pierre Clerson; Pascal de Groote; Marc Humbert
Journal:  Arthritis Rheum       Date:  2005-12

Review 6.  Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

Authors:  J G Lanham; K B Elkon; C D Pusey; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

Review 7.  Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature.

Authors:  P J Jederlinic; L Sicilian; E A Gaensler
Journal:  Medicine (Baltimore)       Date:  1988-05       Impact factor: 1.889

8.  Granulomatous infectious diseases associated with tumor necrosis factor antagonists.

Authors:  R S Wallis; M S Broder; J Y Wong; M E Hanson; D O Beenhouwer
Journal:  Clin Infect Dis       Date:  2004-04-15       Impact factor: 9.079

9.  Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Authors:  D Mukerjee; D St George; B Coleiro; C Knight; C P Denton; J Davar; C M Black; J G Coghlan
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 10.  Pulmonary manifestations of Sjögren's syndrome.

Authors:  H C Cain; P W Noble; R A Matthay
Journal:  Clin Chest Med       Date:  1998-12       Impact factor: 2.878

View more
  1 in total

1.  [Quality of a multidisciplinary orthopaedic-rheumatological consultation].

Authors:  S Mayer-Wagner; F Wiendl; S Schewe; M Grünke; H Schulze-Koops; P Delhey; B M Holzapfel; V Jansson; J Hausdorf
Journal:  Z Rheumatol       Date:  2010-10       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.